In patients with AML in whom U5 snRNP200 cell surface expression was detected on bulk CD34+ malignant cells, U5 snRNP200 was also present on immunophenotypically defined leukemia stem cells (Fig. 2a). Here, CD34 is linked to acute myeloid leukemia.